Clinical Trial

Analyzing Engagement Trends in Rhabdomyosarcoma Clinical Trials

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 8, 2023 (before its estimated October 2025 completion). Its status may not reflect the trial's current state.
Summary
The study seeks to delve into the firsthand experiences of patients diagnosed with rhabdomyosarcoma who partake in a separate clinical trial featuring a specific medical intervention. The primary emphasis will be on meticulously tracking the rates of trial completion and withdrawal among these individuals. The data collected from this study will help improve future outcomes for all rhabdomyosarcoma patients as well as those in under-represented demographic groups.
Trial Details
NCT Number NCT06029465
Lead Sponsor Power Life Sciences Inc.
Conditions Rhabdomyosarcoma
Enrollment 500 participants
Start Date 2024-10
Primary Completion 2025-10 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2023-09-08